9Y8B
Human p38 ALPHA MAPK:MW164 pyridazine inhibitor complex
This is a non-PDB format compatible entry.
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | NSLS-II BEAMLINE 17-ID-1 |
| Synchrotron site | NSLS-II |
| Beamline | 17-ID-1 |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2023-07-27 |
| Detector | DECTRIS EIGER X 9M |
| Wavelength(s) | 0.92010 |
| Spacegroup name | P 21 21 21 |
| Unit cell lengths | 67.039, 74.757, 79.510 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 49.910 - 1.970 |
| R-factor | 0.1831 |
| Rwork | 0.181 |
| R-free | 0.22080 |
| Structure solution method | MOLECULAR REPLACEMENT |
| RMSD bond length | 0.004 |
| RMSD bond angle | 0.782 |
| Data reduction software | autoPROC |
| Data scaling software | Aimless |
| Phasing software | REFMAC |
| Refinement software | PHENIX ((1.20.1_4487: ???)) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 79.510 | 2.080 |
| High resolution limit [Å] | 1.970 | 1.970 |
| Rmerge | 0.116 | 1.208 |
| Rmeas | 0.123 | 1.329 |
| Rpim | 0.040 | 0.503 |
| Number of reflections | 28061 | 3950 |
| <I/σ(I)> | 13.2 | 2.3 |
| Completeness [%] | 97.2 | 95.9 |
| Redundancy | 9.9 | 9.8 |
| CC(1/2) | 0.815 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 5.5 | 292 | Protein: 20.0 mg/ml, 0.15M Sodium chloride, 0.02M Tris-HCl (pH 8.3), 1mM TCEP; Screen: 0.15M Ammomium acetate, 0.1M Bis-Tris (pH 5.5), 16% (w/v) PEG1000; Soak: 24 hrs, 5mM ligand in screen solution; Cryo: 10% Glycerol in screen solution. |






